Microneedle Flu Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microneedle Flu Vaccine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
5.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.4. By Company (2023)
5.3. Market Map
5.3.1 By Product Type
5.3.2 By Vaccine Type
5.3.3 By Region

6. North America Microneedle Flu Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
6.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Microneedle Flu Vaccine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Vaccine Type
6.3.2. Canada Microneedle Flu Vaccine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Vaccine Type
6.3.3. Mexico Microneedle Flu Vaccine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Vaccine Type

7. Europe Microneedle Flu Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
7.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Microneedle Flu Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Vaccine Type
7.3.2. Germany Microneedle Flu Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Vaccine Type
7.3.3. United Kingdom Microneedle Flu Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Vaccine Type
7.3.4. Italy Microneedle Flu Vaccine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Vaccine Type
7.3.5. Spain Microneedle Flu Vaccine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Vaccine Type

8. Asia-Pacific Microneedle Flu Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
8.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Microneedle Flu Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Vaccine Type
8.3.2. India Microneedle Flu Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Vaccine Type
8.3.3. Japan Microneedle Flu Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Vaccine Type
8.3.4. South Korea Microneedle Flu Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Vaccine Type
8.3.5. Australia Microneedle Flu Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Vaccine Type

9. South America Microneedle Flu Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
9.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Microneedle Flu Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Vaccine Type
9.3.2. Argentina Microneedle Flu Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Vaccine Type
9.3.3. Colombia Microneedle Flu Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Vaccine Type
10. Middle East and Africa Microneedle Flu Vaccine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
10.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Microneedle Flu Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Vaccine Type
10.3.2. Saudi Arabia Microneedle Flu Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Vaccine Type
10.3.3. UAE Microneedle Flu Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Vaccine Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Microneedle Flu Vaccine Market: SWOT Analysis
14. Porter?s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Debiotech S.A
15.1.1. Business Overview
15.1.2. Product Offerings
15.1.3. Recent Developments
15.1.4. Financials (As Reported)
15.1.5. Key Personnel
15.1.6. SWOT Analysis
15.2. NanoPass Technologies Limited
15.2.1. Business Overview
15.2.2. Product Offerings
15.2.3. Recent Developments
15.2.4. Financials (As Reported)
15.2.5. Key Personnel
15.2.6. SWOT Analysis
15.3. Becton, Dickinson and Company
15.3.1. Business Overview
15.3.2. Product Offerings
15.3.3. Recent Developments
15.3.4. Financials (As Reported)
15.3.5. Key Personnel
15.3.6. SWOT Analysis
15.4. FluGen, Inc
15.4.1. Business Overview
15.4.2. Product Offerings
15.4.3. Recent Developments
15.4.4. Financials (As Reported)
15.4.5. Key Personnel
15.4.6. SWOT Analysis
15.5. CosMED Pharmaceuticals Co., Ltd
15.5.1. Business Overview
15.5.2. Product Offerings
15.5.3. Recent Developments
15.5.4. Financials (As Reported)
15.5.5. Key Personnel
15.5.6. SWOT Analysis
15.6. Microdermics Inc.
15.6.1. Business Overview
15.6.2. Product Offerings
15.6.3. Recent Developments
15.6.4. Financials (As Reported)
15.6.5. Key Personnel
15.6.6. SWOT Analysis
15.7. TSRL Inc.
15.7.1. Business Overview
15.7.2. Product Offerings
15.7.3. Recent Developments
15.7.4. Financials (As Reported)
15.7.5. Key Personnel
15.7.6. SWOT Analysis
15.8. Vaxess Technologies
15.8.1. Business Overview
15.8.2. Product Offerings
15.8.3. Recent Developments
15.8.4. Financials (As Reported)
15.8.5. Key Personnel
15.8.6. SWOT Analysis
15.9. PFIZER, INC.
15.9.1. Business Overview
15.9.2. Product Offerings
15.9.3. Recent Developments
15.9.4. Financials (As Reported)
15.9.5. Key Personnel
15.9.6. SWOT Analysis
15.10. MERCK & CO., INC.
15.10.1. Business Overview
15.10.2. Product Offerings
15.10.3. Recent Developments
15.10.4. Financials (As Reported)
15.10.5. Key Personnel
15.10.6. SWOT Analysis

16. Strategic Recommendations